Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
284.7 USD | +0.97% | +1.21% | -11.62% |
05-08 | UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating | MT |
05-08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.62% | 8.03B | |
-4.42% | 182B | |
+1.64% | 110B | |
-2.48% | 68.11B | |
+2.26% | 50.53B | |
+9.65% | 44.8B | |
+2.84% | 40.7B | |
+22.22% | 32.25B | |
+3.39% | 26.53B | |
+15.25% | 25.02B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- UBS Initiates Coverage on Bio-Rad Laboratories With Buy Rating, $395 Price Target